Real-time enrollment status for this von willebrand disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:16 AM UTC
| NCT Number | NCT05776069 |
| Recruiting Status | Recruiting |
| Condition | Von Willebrand Disease |
| Phase | PHASE1 |
| Target Enrollment | 116 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Vega Therapeutics, Inc |
| Last Updated on CT.gov | August 26, 2025 (Aug 26, 2025) |
As of July 19, 2026: Clinical trial NCT05776069 is currently recruiting participants. This phase1 study for von willebrand disease is actively seeking new participants at 10 locations across the United States. The study is sponsored by Vega Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05776069 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05776069 was last updated Aug 26, 2025 (August 26, 2025). HelloStudys verifies this status automatically.